Studies demonstrated that PI3K/AKT/mTOR pathway, one of the most important signaling pathways for therapeutic intervention in ovarian cancer, has been reported as the frequently altered signaling pathway in ovarian cancer [23]. This evidence concerns the gene MTOR and ovarian cancer.